Brian Budzik

Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 Receptor Agonists

Karen A. Evans, Brian Budzik, Sean Ross et al. · Journal of Medicinal Chemistry · 2009 · 74 citations · Full text

Medicinal Chemistry, Biochemistry, Tgr5 Receptor Agonists +13

Novel<i>N</i>-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M₁mAChR Agonists

Brian Budzik, Vincenzo Garzya, Dongchuan Shi et al. · ACS Medicinal Chemistry Letters · 2010 · 55 citations · Full text

Synthesis and structure–activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists

Brian Budzik, Karen A. Evans, David D. Wisnoski et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 45 citations · Full text

Diversity Oriented Synthesis, Tgr5 Agonists, Biochemistry +9

Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema Model

Joseph E. Pero, Jay M. Matthews, David J. Behm et al. · Journal of Medicinal Chemistry · 2018 · 34 citations · Full text

The development of an in vitro assay to screen lipid based nanoparticles for siRNA delivery

Ye Zhang, Leticia Arrington, D. I. Boardman et al. · Journal of Controlled Release · 2013 · 28 citations

Nanoparticles, Nanomedicine, Engineering +7